Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulo
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2011.10124.x/fullpdf
Reference26 articles.
1. Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials;Emberton;BJU Int,2008
2. Benign prostatic hyperplasia: a progressive disease of aging men;Emberton;Urology,2003
3. Natural history of benign prostatic hyperplasia;Jacobsen;Urology,2001
4. Natural history of prostatism: risk factors for acute urinary retention;Jacobsen;J Urol,1997
5. Incidence rates and risk factors for acute urinary retention: the health professionals followup study;Meigs;J Urol,1999
Cited by 91 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is there a best timing for benign prostatic hyperplasia surgery?;The French Journal of Urology;2024-03
2. Comparison between combination of tamsulosin and Pentoxifylline versus tamsulosin alone in the treatment of lower urinary tract symptoms due to benign prostate hyperplasia: A preliminary study;LUTS: Lower Urinary Tract Symptoms;2024-01
3. Inhibitory Effects of Pueraria mirifica Aqueous Extracts on 5α-reductase and Prostate Histomorphometry in Testosterone-induced Benign Prostatic Hyperplasia Sprague Dawley Rats;ICMST;2023-08-10
4. Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression;European Urology Focus;2023-01
5. A Prospective, Observational Study of Use Combination Silodosin 8 mg Plus Serenoa Repens, Urtica Dioica, Cucurbita Pepo (Rotaprost) Compared With Silodosin 8 mg Alone in Treatment Patients with Benign Prostate Hyperplasia;Clinical Complementary Medicine and Pharmacology;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3